Acciones Emergent Biosolutions Inc CINNOBER BOAT
Acciones
0IGA
US29089Q1058
Farmacéuticos
Ventas 2024 * | 1015,43 M 940 M | Ventas 2025 * | 1137,79 M 1053,51 M | Capitalización | 324 M 300 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | -155 M -144 M | Resultado Neto 2025 * | -110 M -102 M | VE / Ventas 2024 * | 0,43 x |
Deuda neta 2024 * | 111 M 103 M | Deuda neta 2025 * | 336 M 311 M | VE / Ventas 2025 * | 0,58 x |
P/E ratio 2024 * |
-2,07
x | P/E ratio 2025 * |
-2,94
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 88,38 % |
Último transcript sobre Emergent Biosolutions Inc
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | 21/02 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 26/03/18 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 17/03/23 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 01/04/22 |
Marvin White
BRD | Director/Board Member | 61 | 01/06/10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01/01/05 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+45,82 % | 765 mil M | |
+40,95 % | 632 mil M | |
-6,16 % | 354 mil M | |
+19,86 % | 331 mil M | |
+9,32 % | 299 mil M | |
+18,45 % | 248 mil M | |
-0,78 % | 219 mil M | |
+11,88 % | 216 mil M | |
+5,90 % | 164 mil M |